Selective Uptake of 32p by the Cervix in Patients with Carcinoma Before and After Treatment, and in Normal Subjects
1958

Selective Uptake of 32P by the Cervix in Cancer Patients

Sample size: 32 publication Evidence: moderate

Author Information

Author(s): A. C. Papaloucas

Primary Institution: Royal Marsden Hospital and Institute of Cancer Research

Hypothesis

Does selective uptake of 32P occur in cervical cancer, and can it assess treatment progress?

Conclusion

The study found that cervical carcinoma takes up significantly more 32P than normal tissue, and this uptake decreases after successful treatment.

Supporting Evidence

  • Cervical carcinoma takes up approximately six times more 32P per gram of tissue than normal tissue.
  • In treated patients where the tumor has disappeared, 32P uptake is reduced to near normal levels.
  • In cases with poor response to treatment, 32P uptake remains high, indicating ongoing malignancy.

Takeaway

This study looked at how much a special substance called 32P is taken up by cancer cells in the cervix compared to normal cells, and it found that cancer cells take up a lot more.

Methodology

Patients received 1 mc. of 32P intravenously, and biopsy specimens were taken for radioactivity determination.

Potential Biases

There may be pre-cancerous changes in adjacent tissues that could affect results.

Limitations

The study did not investigate long-term changes in 32P uptake after successful treatment.

Participant Demographics

26 patients with cervical carcinoma and 6 normal subjects, ages ranging from 47 to 70 years.

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication